Addressing gender for PrEP

Share

Pre-exposure prophylaxis (PrEP) was conceived to fill the urgent need for a woman-controlled HIV prevention method. However, biomedical technology alone will not alter the underlying gender inequalities that make women and girls vulnerable to HIV. This technical brief was developed by Michele Lanham from FHI360 – an OPTIONS consortium partner. It focuses on addressing gender while ensuring effective PrEP introduction.

Decriminalisation of drugs

South Africa’s current drug policy framework is fragmented, with contradictions between legislation that criminalises personal drug use and policy commitments that recognise prevention, treatment, harm reductionand social reintegration as essential

Read more »